At Stark Pharma, we provide full-spectrum Clinical Research services covering everything from First-in-Human studies to post-marketing surveillance. Our experienced team manages global clinical trials across all phases, therapeutic areas, and regulatory environments—ensuring quality, compliance, and efficiency at every step.
We integrate Trial Management as a core function within our clinical operations—offering strategic oversight, real-time coordination, and seamless site and patient engagement to deliver results on time and within budget.
We support end-to-end execution of clinical trials from protocol development to close-out, including investigator site management, GCP-compliant monitoring, and data reconciliation.
Our dedicated project managers oversee trial timelines, vendors, budgets, and CROs, acting as the central hub for all trial-related communications and decision-making.
We leverage real-world data and therapeutic insights to identify the right sites and investigators. Our streamlined activation processes ensure fast study startup with minimal delays.
Stark Pharma uses digital tools, site engagement strategies, and community outreach to support efficient enrollment and high retention, especially in complex and rare disease trials.
Our team handles clinical investigations for medical devices in compliance with ISO 14155, FDA IDE, and EU MDR requirements—managing safety, efficacy, and performance data collection.
With operations in the US, EU, and India, we combine global oversight with regional execution—adapting quickly to local regulatory, cultural, and logistical needs.
We ensure that all clinical activities adhere to ICH-GCP, local health authority regulations, and sponsor SOPs. Internal QA, RBM, and audit readiness are built into every study.
We unify trial management and operational execution under one team, reducing handoffs, delays, and compliance risks.
Our hybrid model offers centralized planning and decentralized execution—allowing sponsors to scale studies across geographies with confidence.
From oncology to devices, our clinical team has supported over 150 studies globally with strong therapeutic alignment and scientific credibility.